Evidence map›Paper›PMID 42230557›Full record

ArticleBlood cancer journal2026

Chimeric antigen receptor T-cell therapy is equally effective and safe in older (≥70) and younger patients with multiple myeloma: a multicenter retrospective analysis.

Philipp Berning, Markus Maulhardt, Hristo Boyadzhiev, Anca-Maria Albici, Snjezana Janjetovic, Anna Ossami Saidy, Christian Schultze-Florey, Simon Call, Friedrich Stölzel, Annamaria Brioli and 17 more

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Blood cancer journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

27 authors.

Philipp BerningDepartment of Medicine A, Hematology, Oncology and Pneumology, University Hospital Muenster, Muenster, Germany.ORCID http://orcid.org/0000-0002-4152-0366
Markus MaulhardtDepartment of Hematology and Medical Oncology, University Hospital Goettingen, Goettingen, Germany.ORCID http://orcid.org/0009-0008-7585-8956
Hristo BoyadzhievDepartment of Medical Oncology, Inselspital, University Hospital Bern, University of Bern, Bern, Switzerland.
Anca-Maria AlbiciUniversity Hospital Schleswig-Holstein, Kiel, Division of Stem Cell Transplantation and Cellular Immunotherapies, Kiel University, Kiel, Germany.
Snjezana JanjetovicDepartment of Hematology, Oncology, and Tumor Immunology Helios Klinikum Berlin-Buch, Berlin, Germany.
Anna Ossami SaidyDepartment of Hematology, Oncology, and Tumor Immunology Helios Klinikum Berlin-Buch, Berlin, Germany.
Christian Schultze-FloreyDepartment of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany.
Simon CallDepartment of Medicine A, Hematology, Oncology and Pneumology, University Hospital Muenster, Muenster, Germany.
Friedrich StölzelUniversity Hospital Schleswig-Holstein, Kiel, Division of Stem Cell Transplantation and Cellular Immunotherapies, Kiel University, Kiel, Germany.ORCID http://orcid.org/0000-0003-0653-5332
Annamaria BrioliDepartment of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany.ORCID http://orcid.org/0000-0002-4072-7592
Michael DaskalakisDepartment of Hematology and Central Hematology Laboratory, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
Juliane KnustDepartment of Hematology and Medical Oncology, University Hospital Goettingen, Goettingen, Germany.
Justin HasenkampDepartment of Hematology and Medical Oncology, University Hospital Goettingen, Goettingen, Germany.
Rebecca Wurm-KuczeraDepartment of Hematology, Oncology, and Cancer Immunology, Campus Benjamin Franklin, Charité-Universitätsmedizin Berlin, Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Alexander PohlmannDepartment of Medicine A, Hematology, Oncology and Pneumology, University Hospital Muenster, Muenster, Germany.
Matthias StelljesDepartment of Medicine A, Hematology, Oncology and Pneumology, University Hospital Muenster, Muenster, Germany.ORCID http://orcid.org/0000-0002-9331-5145
Cyrus KhandanpourDepartment of Hematology and Oncology, University Hospital of Schleswig-Holstein, University of Lübeck, Lübeck, Germany.ORCID http://orcid.org/0000-0003-4655-6269
Ulrike BacherDepartment of Hematology and Central Hematology Laboratory, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
Amelie BoquoiDepartment of Hematology and Stem Cell Transplantation, West German Cancer Center and German Cancer consortium (DKTK partner site Essen), University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
Florian H HeidelDepartment of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany.
Hans Christian ReinhardtDepartment of Hematology and Stem Cell Transplantation, West German Cancer Center and German Cancer consortium (DKTK partner site Essen), University Hospital Essen, University of Duisburg-Essen, Essen, Germany.ORCID http://orcid.org/0000-0001-5706-9349
Gerald WulfDepartment of Hematology and Medical Oncology, University Hospital Goettingen, Goettingen, Germany.
Natalie SchubUniversity Hospital Schleswig-Holstein, Kiel, Division of Stem Cell Transplantation and Cellular Immunotherapies, Kiel University, Kiel, Germany.
Bastian von TresckowDepartment of Hematology and Stem Cell Transplantation, West German Cancer Center and German Cancer consortium (DKTK partner site Essen), University Hospital Essen, University of Duisburg-Essen, Essen, Germany.ORCID http://orcid.org/0000-0003-1410-4487
Georg LenzDepartment of Medicine A, Hematology, Oncology and Pneumology, University Hospital Muenster, Muenster, Germany.ORCID http://orcid.org/0000-0002-4728-1693
Thomas Pabst *Department of Medical Oncology, Inselspital, University Hospital Bern, University of Bern, Bern, Switzerland.
Evgenii Shumilov *Department of Medicine A, Hematology, Oncology and Pneumology, University Hospital Muenster, Muenster, Germany. evgenii.shumilov@ukmuenster.de.ORCID http://orcid.org/0000-0003-0178-1729

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID42230557
PMCPMC13230749

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.